Hormone-Resistant Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Hormone-Resistant Prostate Cancer?
There are 1 clinical trial targeting Hormone-Resistant Prostate Cancer tracked by BioSniper.
What is the prevalence of Hormone-Resistant Prostate Cancer?
The estimated prevalence of Hormone-Resistant Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into Hormone-Resistant Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis